ALLK: Allakos Inc Sotuvga nisbatan narx
Allakos Inc. tijorat mahsulotlarining yetishmasligi sababli likvidlik tanqisligi tahdidi va tashqi moliyalashtirishga bog'liqlikka duch kelmoqda. Immun dori vositalari sinovlarining oldindan aytib bo'lmasligi salbiy test natijalari aniqlangan taqdirda narxlar qulashi xavfini yuzaga keltiradi. Ushbu GURU.Markets grafigidagi xarajatlarning savdo hajmi nisbati parametr qiymati ga yetishini ko'rsatmoqda. Kompaniya hozirda biznesni kengaytirishni butunlay to'xtatgan holda, xarajatlarni qisqartirmoqda.
Allakos Inc. (ALLK) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Allakos Inc.|ALLK - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati allakos.com|ALLK - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Allakos Therapeutics|ALLK - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Allakos|Oraliq qoplama koeffitsiyenti allakos.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ALLK - Sof daromad|Kutilayotgan sof daromad Allakos Inc.|ALLK - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati allakos.com|ALLK - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Allakos Therapeutics|ALLK - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Allakos|ALLK - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi allakos.com|ALLK - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Allakos Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:ALLK Allakos Inc
P/S koeffitsiyenti Allakos Inc. (ALLK) bozor qiymatini uning savdo hajmi bilan solishtiradi, bu esa kapitalizatsiyaning daromad generatsiya qilish darajalariga nisbatan adolatli ekanligini baholash imkonini beradi. Yallig'lanish terapiyasi uchun antitanachlar ishlab chiqish nuqtai nazaridan narx-savdo koeffitsiyentini tahlil qilish orqali, investor tadqiqot markazlarining salohiyati haddan tashqari yuqori baholanganmi yoki yo'qligini aniqlashi mumkin, bu esa investitsiya qilingan kapitalning barqarorligini ta'minlash uchun juda muhimdir.
Allakos Inc. raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|KNSA (kiniksa.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Grifols|Narxning daromadga nisbati ADPT|P/S multiplikatori CLDX|P/S multiplikatori Aurinia Corp (AUPH)|Narxning daromadga nisbati BioCryst BCRX|P/S multiplikatori veratx.com VERA|DNTH - Narxning daromadga nisbati|Sotuvga nisbatan narx Pharvaris NV|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|TRML - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|Narx/daromad koeffitsiyenti Upstream Bio, Inc.|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|IMNM: Kapitalizatsiya va daromad nisbati|Gossamer Bio, Inc. - P/S multiplikatori|kalvista.com (KALV) - Kapitalizatsiyaning daromadga nisbati|SEPN (Septerna) - Kapitalizatsiyaning daromadga nisbati|PVLA - Narx/daromad koeffitsiyenti|SVRA (Savara Corp) - P/S multiplikatori|P/S multiplikatori Rigel Corp|Narxning daromadga nisbati AnaptysBio, Inc. (ANAB)|Narxning daromadga nisbati ATXS (astriatx.com)|Narxning daromadga nisbati enGene ENGN|RAPT Therapeutics Inc. - Narxning daromadga nisbati|JBIO - Narxning daromadga nisbati|ACRS - P/S multiplikatori|Kyverna Therapeutics (KYTX) - Narxning daromadga nisbati|Narxning sotuvga nisbati TLSA (tizianalifesciences.com)|CABA (Cabaletta Bio) - P/S multiplikatori|VTYX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori THTX|P/S multiplikatori Avalo Therapeutics Inc (AVTX)|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|Bozor kapitallashuvining daromadga nisbati AGEN|CLYM - Narxning daromadga nisbati|Zura Bio Ltd (ZURA) - Kapitalizatsiyaning daromadga nisbati|ATYR: P/S multiplikatori|Adagene Inc. (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|STTK: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EQ|Narx/daromad koeffitsiyenti connectbiopharm.com|Narxning daromadga nisbati Immunic IMUX|ATRA - Kapitalizatsiyaning daromadga nisbati|IFRX - Narxning daromadga nisbati|x4pharma.com (XFOR) - Kapitalizatsiyaning daromadga nisbati|ACET (adicetbio.com) - Kapitalizatsiyaning daromadga nisbati|Celularity (CELU) - P/S multiplikatori|Narxning daromadga nisbati INmune Bio Corp|Kapitalizatsiya va daromad nisbati BRNS (Barinthus Biotherapeutics Corp)|P/S multiplikatori KZR|SABS - Sotuvga nisbatan narx|P/S multiplikatori AKTX (Akari Therapeutics Plc)|P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning daromadga nisbati|GOVX: Narxning daromadga nisbati|Edesa Biotech, Inc. (EDSA) - Narxning daromadga nisbati|IBIO (ibioinc.com) - Narxning daromadga nisbati|CARM (Carisma Therapeutics Inc) - P/S multiplikatori|P/S multiplikatori XTL Biopharmaceuticals Ltd|Narxning daromadga nisbati Bolt Biotherapeutics (BOLT)|P/S multiplikatori hcwbiologics.com (HCWB)|Narxning daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Sotuvga nisbatan narx|ADTX - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti GRI Bio Inc GRI|XRTX (XORTX) - Kapitalizatsiyaning daromadga nisbati|Vyome Therapeutics - Bozor kapitallashuvining daromadga nisbati|REVB (Revelation Biosciences) - P/S multiplikatori|indaptusrx.com (INDP) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|calcimedica.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori AFMD (Affimed N.V.)|HOOK - Kapitalizatsiyaning daromadga nisbati|IGMS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|OCEA: P/S multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - P/S multiplikatori|Narxning daromadga nisbati Third Harmonic Bio, Inc
